ViroCell Adds J. David Enloe And Dr. Martin Pule To Its Board Of Directors

ViroCell Adds J. David Enloe And Dr. Martin Pule To Its Board Of Directors.

In the NewsFlorence BuchananSeptember 6, 2021CDMO, ViroCell Board of Directors, Scientific Advisory Board, J. David Enloe, Martin Pule, Life Sciences Review, UK CDMO, viral vectors, vector design

BioSpace Movers & Shakers

ViroCell Biologics – David Enloe was appointed to the board of directors of ViroCell and Martin Pule was appointed to the company’s Scientific Advisory Board.

In the NewsFlorence BuchananAugust 20, 2021ViroCell Board of Directors, Scientific Advisory Board, David Enloe, Lonza, University College London, gene therapy, cell therapy, CGT, viral vectors, European Patent Office, University College Hospital, Recro Pharma, BioSpace

ViroCell Announces new Board appointments

ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today announces the appointment of J. David Enloe, Jr. to its Board of Directors and Martin Pule, MD, PhD to its Scientific Advisory Board, both leaders in their respective fields.

ViroCell Announces New Board Appointments

ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today announces the appointment of J. David Enloe, Jr. to its Board of Directors and Martin Pule, MD, PhD to its Scientific Advisory Board, both leaders in their respective fields.

In the news

London New York